Patents Assigned to UBI PHARMA INC.
  • Patent number: 10428129
    Abstract: A recombinant protein is provided. The recombinant protein of the invention comprises an erythropoietin and a highly glycosylated peptide, and has a longer half-life. Further, the recombinant protein of the invention may also comprise a carboxyl-terminal peptide of human chorionic gonadotropin and a carboxyl-terminal peptide of thrombopoietin.
    Type: Grant
    Filed: December 16, 2013
    Date of Patent: October 1, 2019
    Assignee: UBI PHARMA INC.
    Inventors: Wen-Jiun Peng, Shu-Ping Yang, Hung-Chih Peng, Yu-Hung Chen